Co-infection of HIV and HCV Among Patients Under Antiretroviral Treatment: Insights from Selected Healthcare Facilities in Ilorin, Nigeria - Top-Institutions - MDSpire

Co-infection of HIV and HCV Among Patients Under Antiretroviral Treatment: Insights from Selected Healthcare Facilities in Ilorin, Nigeria

  • By

  • Felicia E. Williams

  • Jane-Frances I. John-Benson

  • Winifred D. Giwa

  • David U. Adje

  • Louis O. Odeigah

  • Chinonyerem O. Iheanacho

  • Isabel N. Aika

  • January 22, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Hepatology
    • Epidemiology

  • #2

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Infectious Diseases
    • Hepatology
    • Public Health

  • #3

    University of KwaZulu-Natal
    University of KwaZulu-Natal

    Durban, KwaZulu-Natal

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Public Health

  • #4

    University of Lagos College of Medicine
    University of Lagos College of Medicine

    Lagos, Lagos

    Key Differentiators

    • Infectious Diseases
    • Hepatology
    • Public Health

  • #5

    University of Ilorin Teaching Hospital
    University of Ilorin Teaching Hospital

    Ilorin, Kwara

    Key Differentiators

    • Infectious Diseases
    • Hepatology

Original Source(s)

Co-infection of HIV and HCV Among Patients Under Antiretroviral Treatment: Insights from Selected Healthcare Facilities in Ilorin, Nigeria

  • by Felicia E. Williams, Jane-Frances I. John-Benson, Winifred D. Giwa, David U. Adje, Louis O. Odeigah, Chinonyerem O. Iheanacho, Isabel N. Aika

  • January 22, 2026

Related Content

Development of a Rapid Automated Point-of-Care Test for Hepatitis C Viral RNA on the DASH Rapid Polymerase Chain Reaction System

Retrospective Analysis of Direct-Acting Antiviral Treatment Outcomes in Hepatitis C Patients in Saudi Arabia Before and After Therapy

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.